OR7E155P

Across TCGA pan-cancer cohorts, OR7E155P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR7E155P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR7E155P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E155P expression acts as an unfavorable survival marker, although some lineages such as ESCA and PAAD show a favorable association.

ACC, READ, and ESCA are the cancer types where OR7E155P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.155	0.640	.002	54	view →
READ	DFS	Tertile	II,III,IV	0.391	0.824	.001	42	view →
ESCA	OS	Quartile	III,IV	0.818	0.340	.003	41	view →
KIRC	DFS	Tertile	IV	0.300	0.629	.010	30	view →
PAAD	DFS	Tertile	II,III,IV	0.728	0.396	.010	21	view →
STAD	DFS	Tertile	IV	0.097	0.412	.008	19	view →
KICH	DFS	Tertile	All	0.521	0.969	.037	18	view →
THCA	DFS	Tertile	IV	0.568	0.963	.004	18	view →
THYM	DFS	Tertile	II,III,IV	0.426	0.897	.008	12	view →
CHOL	OS	Tertile	All	0.279	0.735	.011	9	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
LGG	DFS	Median	All	0.872	0.777	.031	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR7E155P–ACC (OS)

Open the ACC breakdown →